Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: The ECRIT study

Expert Opinion on Drug Safety

Volumn 11, Issue 1, 2012, Pages 7-13

  Sieber, Jochen ^a   Neis, Mark ^b   Brehler, Randolf ^c   Fölster Holst, Regina ^d   Kapp, Alexander ^e   Klimek, Ludger ^f   Merk, Hans ^b  

^a Stallergenes GmbH   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Center of Rhinology   (Germany)

Author keywords

Allergic rhinitis; Co seasonal treatment; Grass pollen extract; Sublingual immunotherapy; Tolerability; Ultra rush titration

Indexed keywords

GRASS POLLEN EXTRACT; PLACEBO;

ABDOMINAL PAIN; ACNE; ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ANAPHYLAXIS; APPLICATION SITE INFECTION; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; ARTICLE; ASTHMA; BACKACHE; CHILD; CONTROLLED STUDY; CYSTITIS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; EDEMA; GASTROINTESTINAL DISEASE; GRASS POLLEN; HUMAN; IMMUNOREACTIVITY; INFLUENZA; INTERVERTEBRAL DISK HERNIA; LIGAMENT INJURY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; ORCHARD; PHLEUM PRATENSE; POLLEN ALLERGY; PREGNANCY DISORDER; RANDOMIZED CONTROLLED TRIAL; RYE; SCHOOL CHILD; SINUSITIS; SUBLINGUAL IMMUNOTHERAPY; THALICTRUM; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; CHILD; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84555196596     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2012.626765     Document Type: Article

References (27)

1. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011;11(6):740-52
2. Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006;61(Suppl 81):20-3
3. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160 (Pubitemid 351357811)
4. Canonica GW, Bousquet J, Casale T, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009;64(Suppl 91):1-59
5. Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol 2005;15(1):9-16 (Pubitemid 40547626)
6. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120(6):1338-45 (Pubitemid 350225683)
7. Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123(1):160-6; e3
8. Malling HJ. Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: methodological approaches and experimental results. Curr Opin Allergy Clin Immunol 2004;4(6):539-42
9. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60(1):4-12
10. Di Rienzo V, Pagani A, Parmiani S, et al. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54(10):1110-13 (Pubitemid 29482012)
11. Grosclaude M, Bouillot P, Alt R, et al. Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study. Int Arch Allergy Immunol 2002;129(3):248-53 (Pubitemid 35365366)
12. Rossi RE, Monasterolo G. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005;18(2):277-85 (Pubitemid 40825890)
13. Vervloet D, Birnbaum J, Laurent P, et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;142(3):239-46
14. Durham SR, Emminger W, Kapp A, et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010;125(1):131-8; e1-7
15. Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64(9):1394-401
16. GINA (Global Initiative for Asthma). Global strategy for asthma management and prevention. Workshop Report; 2009 December 2008
17. Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(3 Suppl):S25-85
18. Madonini E, Agostinis F, Barra R, et al. Long-term and preventive effects of sublingual allergen-specific immunotherapy: a retrospective, multicentric study. Int J Immunopathol Pharmacol 2003;16(1):73-9 (Pubitemid 36268144)
19. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33(2):206-10 (Pubitemid 36241378)
20. Bodtger U, Poulsen LK, Malling HJ. Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33(4):496-500 (Pubitemid 36520914)
21. CMS Update. Desensitising vaccines. Br Med J (Clin Res Ed) 1986;293:948
22. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92(1 Pt 1):6-15 (Pubitemid 23234076)
23. Guerra L, Compalati E, Rogkakou A, et al. Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy. Allergol Immunopathol (Madr) 2006;34(2):82-3 (Pubitemid 43844848)
24. De Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009;64(6):963-4
25. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97(2):141-8 (Pubitemid 44272577)
26. Penagos M, Passalacqua G, Compalati E, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008;133(3):599-609 (Pubitemid 351367366)
27. Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005;35(5):565-71 (Pubitemid 40769278)